Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosra Moria

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pituitary|February 25, 2019
Increased androgen secretion in patients with prolactinomas: the impact of altered HPA functionYosra Moria, Rouba Kortbawi, Nadine El-Asmar, et al.
European Thyroid Journal|June 28, 2021
Natural Course of the American Thyroid Association Response to Therapy Statuses (Dynamic Risk Stratification) in Differentiated Thyroid CancerNoha Mukhtar, Hadeel Aljamei, Abeer Aljomaiah, et al.
Endocrine|August 18, 2020
One genotype, many phenotypes: SDHB p.R90X mutation-associated paragangliomasAli S Alzahrani, Meshael Alswailem, Yosra Moria, et al.
Journal of the Endocrine Society|December 28, 2020
Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid CancerAli S Alzahrani, Yosra Moria, Noha Mukhtar, et al.
Frontiers in Endocrinology|December 28, 2023
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline <i>SDHB</i> pathogenic variant in the absence of paraganglioma or pheochromocytomaAli S Alzahrani, Abdulghani Bin Nafisah, Meshael Alswailem, et al.
Endocrine|June 27, 2019
Correction to: Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancerAli S Alzahrani, Avaniyapuram Kannan Murugan, Ebtesam Qasem, et al.
Endocrine|October 1, 2018
Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancerAli S Alzahrani, Avaniyapuram Kannan Murugan, Ebtesam Qasem, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2018
Lung Metastasis in Pediatric Thyroid Cancer: Radiological Pattern, Molecular Genetics, Response to Therapy, and OutcomeAli S Alzahrani, Meshael Alswailem, Yosra Moria, et al.
Oncotarget|November 1, 2019
Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paragangliomaShatha Albattal, Meshael Alswailem, Yosra Moria, et al.
Kidney International|March 6, 2021
A novel claudin-10 mutation with a unique mechanism in two unrelated families with HELIX syndromeAli S Alzahrani, Maged Hussein, Meshael Alswailem, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pituitary|February 25, 2019
Increased androgen secretion in patients with prolactinomas: the impact of altered HPA functionYosra Moria, Rouba Kortbawi, Nadine El-Asmar, et al.
European Thyroid Journal|June 28, 2021
Natural Course of the American Thyroid Association Response to Therapy Statuses (Dynamic Risk Stratification) in Differentiated Thyroid CancerNoha Mukhtar, Hadeel Aljamei, Abeer Aljomaiah, et al.
Endocrine|August 18, 2020
One genotype, many phenotypes: SDHB p.R90X mutation-associated paragangliomasAli S Alzahrani, Meshael Alswailem, Yosra Moria, et al.
Journal of the Endocrine Society|December 28, 2020
Course and Predictive Factors of Incomplete Response to Therapy in Low- and Intermediate-Risk Thyroid CancerAli S Alzahrani, Yosra Moria, Noha Mukhtar, et al.
Frontiers in Endocrinology|December 28, 2023
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline <i>SDHB</i> pathogenic variant in the absence of paraganglioma or pheochromocytomaAli S Alzahrani, Abdulghani Bin Nafisah, Meshael Alswailem, et al.
Endocrine|June 27, 2019
Correction to: Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancerAli S Alzahrani, Avaniyapuram Kannan Murugan, Ebtesam Qasem, et al.
Endocrine|October 1, 2018
Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancerAli S Alzahrani, Avaniyapuram Kannan Murugan, Ebtesam Qasem, et al.
The Journal of Clinical Endocrinology and Metabolism|October 2, 2018
Lung Metastasis in Pediatric Thyroid Cancer: Radiological Pattern, Molecular Genetics, Response to Therapy, and OutcomeAli S Alzahrani, Meshael Alswailem, Yosra Moria, et al.
Oncotarget|November 1, 2019
Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paragangliomaShatha Albattal, Meshael Alswailem, Yosra Moria, et al.
Kidney International|March 6, 2021
A novel claudin-10 mutation with a unique mechanism in two unrelated families with HELIX syndromeAli S Alzahrani, Maged Hussein, Meshael Alswailem, et al.
Pageof 2